Russell Investments Group, Ltd. Tyme Technologies, Inc. Transaction History

Russell Investments Group, Ltd.

  • $60.3 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 08, 2021
SELL
$0.99 - $1.38 $80,053 - $111,589
-80,862 Closed
0 $0
Q4 2020

Feb 08, 2021
SELL
$0.87 - $1.26 $556,516 - $805,989
-639,674 Reduced 88.78%
80,862 $98,000
Q3 2020

Nov 09, 2020
BUY
$0.93 - $1.35 $16,691 - $24,229
17,948 Added 2.55%
720,536 $704,000
Q2 2020

Aug 05, 2020
BUY
$0.97 - $1.7 $681,510 - $1.19 Million
702,588 New
702,588 $936,000

About TYME TECHNOLOGIES, INC.

TYME Quotes by TradingView
  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email